India’s growth story as a medical tourism hub is a relatively newer one. With significant cost advantages, availability of quality medical treatment with the most-advanced medical technology coupled with India’s well-known tourist destinations and rich cultural heritage,medical tourism does provide a motive sufficient enough to allure those foreign patients who either want to avoid the long waiting list for medical treatment in the West or, in absence of any health insurance coverage, seek lower cost treatment. India’s strength in advanced and life saving healthcare such as organ transplants, cardio-vascular surgery,etc, as well as in alternative systems of medicine(i.e. ayurveda, naturopathy,etc) offer significant competitive advantages. Cashing in this opportunity, The National Health Policy 2002 declared that treatment of foreign patients is legally an “export” and deemed “eligible for all fiscal incentives extended to export earnings”. Besides, a new category of visa, “Medical Visa” has been introduced by Ministry of Home Affairs, Govt. of India. On the other hand, setting up of Bio-Technology Parks Society of India, grant of SEZ status to them, coming up Medicities, entry of private players in health insurance in India along with Indian hospitals looking for international accreditation glitter further hopes of accelerated medical tourism, a growth engine for foreign exchange earnings.
However, the poor infrastructure of the country, shabby streets, pity state of our public hospitals shakens our confidence,despairs for this much hype of medical tourism and calls for serious attention wherein much more efforts are needed. Definitely,public-private partnership is one way ahead which can revamp public hospitals and bring them at par with other private hospitals.Further, there is still no Medical Tourism Policy either formulated by the Central or any of the States Governments. As the medical tourism industry is growing exponentially, government and the private players need to join hands in order to act as a catalyst to build infrastructure for hospitals, create specialty tourist packages to include medical treatment, promote accreditation and standardisation, enable access and tie-ups with insurance companies, provide state of art facilities and improve quality of in-patient care and service to meet the requirements of foreign patients and to attain sustainable competitive advantage.
Table of Contents
DESTINATION INDIA: “FIRST WORLD TREATMENT AT THIRD WORLD PRICES”:
THE COMPETITION AHEAD:
GOVERNMENT POLICY/INITIATIVES:
SETTING UP OF BPSI:
MEDICITIES: ANOTHER FEATHER IN THE CAP
CHALLENGES AHEAD: WORKFORCE RELATED CHALLENGES:
LEVERAGING AND RETAINING THE TALENT POOL
CARE FOR POOR:
HEALTH INSURANCE: THE CHANGING LANSCAPE
STANDARDIZATION OF HEALTHCARE DELIVERY SYSTEMS
PUBLIC PRIVATE PARTNERSHIPS:
CONCLUSION:
Research Objectives and Themes
This paper examines the rapid emergence of India as a global medical tourism hub, analyzing the drivers behind this growth, including cost advantages and technological advancements, while critically evaluating infrastructure challenges and the necessity for integrated policy development.
- Cost-effectiveness and quality of Indian healthcare services compared to Western standards.
- Government initiatives and policy frameworks supporting medical tourism and biotech expansion.
- The rise of "Medicities" and their impact on medical education and clinical research.
- Workforce retention and the imperative of human capital development in the healthcare sector.
- Standardization, international accreditation, and the role of Public-Private Partnerships.
Excerpt from the Book
DESTINATION INDIA: “FIRST WORLD TREATMENT AT THIRD WORLD PRICES”:
The Indian success story is the outcome of low cost advantages vis-à-vis quality medical treatment. Whereas the cost of treatment in other developed nations especially in the U.S.,U.K.,etc is very high, India can provide quality healthcare at very low cost due to the availability of relatively cheaper but quality manpower, low priced drugs,and other infrastructure. Whereas a liver transplant costs you 5,00,000 US$ in USA,it can only be done with 40,000 US $ in India. Further, a heart surgery can be done with 5,000-7,000 US $ in India as against 30,000 US $ in USA. ( See Figure 1).
This cost effectiveness does make India a destination where “First World Treatment at Third World Prices” (Gupta, 2004) has rather become a reality to reckon with for foreign as well as Non-resident Indians. Adds Dr. Naresh Trehan, "Now we do over 4,000 heart operations a year, and the mortality, which is an index of how well things are, is 0.8 % which is even better than most places in the world. The other thing that we measure is infection rate. Ours is 0.3 % as compared to the world average of 1%."
In terms of advanced medical technology, Indian corporate hospitals now excel in all sorts of critical treatment. Indian surgical techniques are similar to those carried out in the west. Each test is carried out by professional M.D. physicians, and is comprehensive yet pain-free.There is also a gamut of services ranging from General Radiography, Ultra Sonography, Mammography to high end services like Magnetic Resonance Imaging, Digital Subtraction Angiography along with intervention procedures, Nuclear Imaging. The diagnostic facilities offered in India are comprehensive to include Laboratory services, Imaging, Cardiology, Neurology and Pulmonology.
Summary of Chapters
DESTINATION INDIA: “FIRST WORLD TREATMENT AT THIRD WORLD PRICES”: Analyzes India's cost-competitive advantages in complex medical procedures and its growing appeal as a healthcare destination for foreign patients.
THE COMPETITION AHEAD: Compares India’s standing against other regional competitors like Thailand, South Africa, and Singapore across various medical tourism segments.
GOVERNMENT POLICY/INITIATIVES: Details the fiscal and administrative measures, including the "Medical Visa" and tax incentives, aimed at promoting medical tourism.
SETTING UP OF BPSI: Explores the establishment of the Biotechnology Parks Society of India to foster private investment and research in biotechnology.
MEDICITIES: ANOTHER FEATHER IN THE CAP: Discusses the emergence of large-scale, integrated healthcare clusters designed to unify education, research, and high-end clinical treatment.
CHALLENGES AHEAD: WORKFORCE RELATED CHALLENGES: Examines the shortage of trained medical staff and the strategic need to reverse the brain drain of Indian physicians.
LEVERAGING AND RETAINING THE TALENT POOL: Focuses on the requirement to improve infrastructure and remuneration to retain skilled healthcare professionals within India.
CARE FOR POOR: Highlights the ethical dilemma of focusing on lucrative medical tourism versus providing affordable, equitable healthcare to India’s domestic low-income population.
HEALTH INSURANCE: THE CHANGING LANSCAPE: Analyzes the evolution of the health insurance market and its potential to democratize access to advanced healthcare.
STANDARDIZATION OF HEALTHCARE DELIVERY SYSTEMS: Emphasizes the importance of international accreditation (like JCI and NABH) in building global trust and operational quality.
PUBLIC PRIVATE PARTNERSHIPS: Advocates for collaborative models between the state and private sectors to optimize resource utilization and infrastructure development.
CONCLUSION: Summarizes the need for a unified national policy and strategic industry collaboration to ensure the long-term sustainability of India’s medical tourism growth.
Keywords
Medical Tourism, Healthcare, India, Cost Advantage, Biotechnology, Medicities, Medical Visa, Healthcare Infrastructure, Public-Private Partnership, Accreditation, NABH, JCI, Health Insurance, Human Capital, Global Competitiveness.
Frequently Asked Questions
What is the primary focus of this publication?
The work provides a comprehensive analysis of the medical tourism industry in India, exploring its growth drivers, policy environment, and the structural challenges the sector faces.
Which sectors of the economy are most affected by the rise of medical tourism in India?
The primary sectors include healthcare services, medical education, pharmaceutical and biotech research, and the broader travel and hospitality industry.
What is the central research question posed by the authors?
The authors investigate whether India can sustain its momentum as a global medical tourism leader while simultaneously addressing domestic healthcare equity and infrastructure gaps.
What methodologies are employed in this analysis?
The paper utilizes an industry-level descriptive analysis, integrating statistical data on costs, government reports, and institutional studies to evaluate market performance.
What are the core components of the "Medicities" concept mentioned in the study?
Medicities are large, multi-disciplinary hospital clusters that combine clinical care with academic research, specialized training, and high-end infrastructure.
Which keywords define the scope of this research?
The research is defined by terms such as medical tourism, healthcare accreditation, private-public collaboration, and infrastructure development.
How does India's medical technology investment compare to its regional competitors?
India maintains a strong competitive advantage in advanced clinical procedures at significantly lower costs, supported by heavy investment in state-of-the-art diagnostic and surgical technology.
What is the specific role of the National Accreditation Board for Hospitals (NABH) in India?
The NABH serves to standardize healthcare delivery in India, ensuring safety, uniform access, and quality benchmarks that align with international expectations.
How is the "brain drain" issue addressed in the context of the Indian medical workforce?
The study argues for the development of world-class infrastructure and competitive compensation to retain talent and encourage the return of Indian doctors currently working abroad.
- Quote paper
- Senior Lecturer Ambuj Gupta (Author), Vinay Sharma (Author), 2008, Medical tourism: on the growth track in India, Munich, GRIN Verlag, https://www.grin.com/document/87957
